Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Opna Bio is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.
Cortica provides neurological therapies for children with autism and other developmental differences.
Polares medical is a medical device company with a novel device for treating mitral valve regurgitation.
Ventaris Surgical is a medical equipment company that provides surgical instruments to specialists.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.
Cohere Health is a SaaS company that focuses on improving the efficiency and effectiveness of healthcare delivery.
89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
CuraSen Therapeutics is a biopharmaceutical company that develops orphan drugs to treat neurodegenerative diseases
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better.
Aptinyx Inc. is a biopharmaceutical company.
Tricida operates in the healthcare industry focusing on pharmaceutical business.
Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
IntelyCare is revolutionizing healthcare staffing, scheduling, and training by offering an enterprise workforce management platform.
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.
Sydnexis is engaged in the development of a proprietary treatment for pediatric progressive myopia.
Longitude Capital has invested in 62 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Longitude Capital's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Medical Device. The firm invests across 21 different industry categories.
Among tracked funding rounds, 89bio received $287.5M in a Post Ipo Equity round. Longitude Capital's total known invested capital is $3.8B.
Longitude Capital's average investment size is $76.9M across its portfolio of 62 companies.
Recent Longitude Capital portfolio additions include Opna Bio, Cortica, Polares Medical, Ventaris Surgical, AirNexis Therapeutics. These companies were founded in 2020 or later.